GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medimi AB (XSAT:MEDIMI) » Definitions » Cash Flow from Financing

Medimi AB (XSAT:MEDIMI) Cash Flow from Financing : kr0.68 Mil (TTM As of Sep. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Medimi AB Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Sep. 2024, Medimi AB paid kr0.14 Mil more to buy back shares than it received from issuing new shares. It spent kr0.06 Mil paying down its debt. It paid kr0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received kr0.00 Mil from paying cash dividends to shareholders. It received kr0.00 Mil on other financial activities. In all, Medimi AB spent kr0.20 Mil on financial activities for the three months ended in Sep. 2024.


Medimi AB Cash Flow from Financing Historical Data

The historical data trend for Medimi AB's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medimi AB Cash Flow from Financing Chart

Medimi AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.82 0.07 23.47 15.42 15.75

Medimi AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -0.06 0.93 -0.20

Medimi AB Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Medimi AB's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

Medimi AB's Cash from Financing for the quarter that ended in Sep. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medimi AB  (XSAT:MEDIMI) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Medimi AB's issuance of stock for the three months ended in Sep. 2024 was kr0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Medimi AB's repurchase of stock for the three months ended in Sep. 2024 was kr-0.14 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Medimi AB's net issuance of debt for the three months ended in Sep. 2024 was kr-0.06 Mil. Medimi AB spent kr0.06 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Medimi AB's net issuance of preferred for the three months ended in Sep. 2024 was kr0.00 Mil. Medimi AB paid kr0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Medimi AB's cash flow for dividends for the three months ended in Sep. 2024 was kr0.00 Mil. Medimi AB received kr0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Medimi AB's other financing for the three months ended in Sep. 2024 was kr0.00 Mil. Medimi AB received kr0.00 Mil on other financial activities.


Medimi AB Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Medimi AB's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Medimi AB Business Description

Traded in Other Exchanges
N/A
Address
Zinkgatan 2, Lomma, SWE, 234 35
Medimi AB is engaged in the development, production, and marketing of medication products. It offers Medimi Pro and Medimi Smart computerized pill dispensers that are used by patients, consumers, and healthcare staff to follow their drug schedule. The company focus on the following market segments namely Pharmaceutical industry, Hospital and retirement homes, Home Health Care, Pharmacy and private care, and Connected Health (Telemedicine), E-Health and Integration in Other Systems.

Medimi AB Headlines

No Headlines